ChronoScale Corporation Common Stock (NASDAQ:CHRN) Shares Cross Above 50-Day Moving Average – Time to Sell?

ChronoScale Corporation Common Stock (NASDAQ:CHRN)’s stock price passed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $17.21 and traded as high as $22.59. ChronoScale Corporation Common Stock shares last traded at $17.64, with a volume of 805,758 shares.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of ChronoScale Corporation Common Stock in a research note on Friday, March 27th. One analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Reduce” and a consensus price target of $6.00.

ChronoScale Corporation Common Stock Trading Down 20.6%

The firm has a market cap of $62.80 million, a PE ratio of -3.28 and a beta of 0.99. The company has a 50 day simple moving average of $17.21 and a two-hundred day simple moving average of $12.03. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.03 and a current ratio of 1.55.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last announced its quarterly earnings results on Tuesday, April 28th. The company reported ($2.04) earnings per share for the quarter, missing the consensus estimate of ($0.03) by ($2.01). The company had revenue of $2.14 million for the quarter, compared to analysts’ expectations of $4.29 million. ChronoScale Corporation Common Stock had a negative net margin of 135.66% and a negative return on equity of 197.81%. Analysts expect that ChronoScale Corporation Common Stock will post -0.1 EPS for the current fiscal year.

Institutional Trading of ChronoScale Corporation Common Stock

Institutional investors have recently bought and sold shares of the business. Roble Belko & Company Inc lifted its position in shares of ChronoScale Corporation Common Stock by 104.5% during the 1st quarter. Roble Belko & Company Inc now owns 2,338 shares of the company’s stock valued at $25,000 after buying an additional 1,195 shares in the last quarter. Virtu Financial LLC acquired a new stake in ChronoScale Corporation Common Stock during the third quarter worth about $57,000. Shay Capital LLC acquired a new stake in shares of ChronoScale Corporation Common Stock during the 3rd quarter worth approximately $67,000. Citadel Advisors LLC acquired a new position in shares of ChronoScale Corporation Common Stock in the 3rd quarter valued at $198,000. Finally, Geode Capital Management LLC boosted its stake in ChronoScale Corporation Common Stock by 68.9% during the fourth quarter. Geode Capital Management LLC now owns 25,212 shares of the company’s stock worth $218,000 after buying an additional 10,281 shares during the period. 6.42% of the stock is owned by institutional investors and hedge funds.

About ChronoScale Corporation Common Stock

Ekso Bionics Holdings, Inc (NASDAQ:EKSO) is a leading developer of wearable bionic exoskeletons designed to enhance human mobility and strength. Headquartered in Richmond, California, the company was founded in 2005 (originally as Berkeley Bionics) and completed its initial public offering in 2014. Its patented robotic systems support both rehabilitation and industrial applications by providing powered, adjustable assistance for a range of movement tasks.

In the medical sector, Ekso Bionics offers externally worn exoskeletons such as the EksoNR and EksoGT, which assist patients recovering from stroke, spinal cord injury or other neurological conditions.